Immunological effects of transglutaminase-treated gluten in coeliac disease

Human Immunology

Volumn 73, Issue 10, 2012, Pages 992-997

  Elli, Luca ^a   Roncoroni, Leda ^a   Hils, Martin ^b   Pasternack, Ralf ^b   Barisani, Donatella ^c   Terrani, Claudia ^a   Vaira, Valentina ^a   Ferrero, Stefano ^a,d   Bardella, Maria Teresa ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b ZEDIRA GMBH   (Germany)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTEN; LACTATE DEHYDROGENASE; LYSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RECOMBINANT ENZYME;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BIOPSY; CELIAC DISEASE; DUODENUM; FEMALE; GLUTENS; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; LYSINE; MALE; MIDDLE AGED; TRANSGLUTAMINASES; TREATMENT OUTCOME;

EID: 84866356187     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.318     Document Type: Article

References (34)

1. Elli L., Bergamini C.M., Bardella M.T., Schuppan D. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis 2009, 41(8):541.
2. D'Arienzo R., Stefanile R., Maurano F., Luongo D., Bergamo P., Mazzarella G., Troncone R., Auricchio S., David C., Rossi M. A deregulated immune response to gliadin causes a decreased villus height in DQ8 transgenic mice. Eur J Immunol 2009, 39(12):3552.
3. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G.M., Sollid L.M., Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 2002, 297(5590):2275.
4. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997, 3(7):797.
5. Dieterich W., Esslinger B., Schuppan D. Pathomechanisms in celiac disease. Int Arch Allergy Immunol 2003, 132(2):98.
6. Fleckenstein B., Molberg O., Qiao S.W., Schmid D.G., von der Mulbe F., Elgstoen K., Jung G., Sollid L.M. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem 2002, 277(37):34109.
7. Berti C., Roncoroni L., Falini M.L., Caramanico R., Dolfini E., Bardella M.T., Elli L., Terrani C., Forlani F. Celiac-related properties of chemically and enzymatically modified gluten proteins. J Agric Food Chem 2007, 55(6):2482.
8. Falini M.L., Elli L., Caramanico R., Bardella M.T., Terrani C., Roncoroni L., Doneda L., Forlani F. Immunoreactivity of antibodies against transglutaminase-deamidated gliadins in adult celiac disease. Dig Dis Sci 2008, 53:2697.
9. Bardella M.T., Molteni N., Prampolini L., Giunta A.M., Baldassarri A.R., Morganti D., Bianchi P.A. Need for follow up in coeliac disease. Arch Dis Child 1994, 70(3):211.
10. Nachman F., del Campo M.P., Gonzalez A., Corzo L., Vazquez H., Sfoggia C., Smecuol E., Sanchez M.I., Niveloni S., Sugai E., Maurino E., Bai J.C. Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis 2010, 42(10):685.
11. Caputo I., Lepretti M., Martucciello S., Esposito C. Enzymatic strategies to detoxify gluten: implications for celiac disease. Enzyme Res 2010, 174354.
12. Oberhuber G., Granditsch G., Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999, 11(10):1185.
13. Korponay-Szabo I.R., Halttunen T., Szalai Z., Laurila K., Kiraly R., Kovacs J.B., Fesus L., Maki M. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004, 53(5):641.
14. Rantala I., Maki M., Laasonen A., Visakorpi J.K. Periodate-lysine-paraformaldehyde as fixative for the study of duodenal mucosa. Morphologic and immunohistochemical results at light and electron microscopic levels. Acta Pathol Microbiol Immunol Scand A 1985, 93(4):165.
15. Tack G.J., Verbeek W.H., Schreurs M.W., Mulder C.J. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010, 7(4):204.
16. Schuppan D., Dennis M.D., Kelly C.P. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr Clin Care 2005, 8(2):54.
17. Bardella M.T., Velio P., Cesana B.M., Prampolini L., Casella G., Di Bella C., Lanzini A., Gambarotti M., Bassotti G., Villanacci V. Coeliac disease: a histological follow-up study. Histopathology 2007, 50(4):465.
18. Dorum S, Arntzen MO, Qiao SW, Holm A, Koehler CJ, Thiede B, Sollid LM, Fleckenstein B: The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One 5(11):e14056.
19. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137(6):1912.
20. Osorio C., Wen N., Gemini R., Zemetra R., von Wettstein D., Rustgi S. Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics 2012.
21. Domingo J.L., Gine Bordonaba J. A literature review on the safety assessment of genetically modified plants. Environ Int 2011, 37(4):734.
22. Griffin M., Casadio R., Bergamini C.M. Transglutaminases: nature's biological glues. Biochem J 2002, 368(Pt 2):377.
23. Molberg O., McAdam S., Lundin K.E., Kristiansen C., Arentz-Hansen H., Kett K., Sollid L.M. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol 2001, 31(5):1317.
24. Sjostrom H., Lundin K.E., Molberg O., Korner R., McAdam S.N., Anthonsen D., Quarsten H., Noren O., Roepstorff P., Thorsby E., Sollid L.M. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 1998, 48(2):111.
25. Molberg O., McAdam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Noren O., Roepstorff P., Lundin K.E., Sjostrom H., Sollid L.M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998, 4(6):713.
26. Lundin K.E., Sollid L.M., Anthonsen D., Noren O., Molberg O., Thorsby E., Sjostrom H. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology 1997, 112(3):752.
27. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., Londei M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003, 362(9377):30.
28. Gianfrani C., Siciliano R.A., Facchiano A.M., Camarca A., Mazzeo M.F., Costantini S., Salvati V.M., Maurano F., Mazzarella G., Iaquinto G., Bergamo P., Rossi M. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 2007, 133(3):780.
29. Stamnaes J., Fleckenstein B., Sollid L.M. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta 2008, 1784(11):1804.
30. D'Argenio G., Calvani M., Della Valle N., Cosenza V., Di Matteo G., Giorgio P., Margarucci S., Petillo O., Jori F.P., Galderisi U., Peluso G. Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis. Gut 2005, 54(4):496.
31. Stenberg P., Roth E.B., Sjoberg K. Transglutaminase and the pathogenesis of coeliac disease. Eur J Intern Med 2008, 19(2):83.
32. Nachman F, del Campo MP, Gonzalez A, Corzo L, Vazquez H, Sfoggia C, Smecuol E, Sanchez MI, Niveloni S, Sugai E, Maurino E, Bai JC: Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis 42(10):685.
33. Yokoyama K., Nio N., Kikuchi Y. Properties and applications of microbial transglutaminase. Appl Microbiol Biotechnol 2004, 64(4):447.
34. Elli L. Coeliac disease: between "pizza" and ethics. Gut 2006, 55(11):1672.